Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapySabina Kaczanowska(National Institutes of Health), Rosandra N. Kaplan(National Cancer Institute)Cancer CellDecember 21, 202310.1016/j.ccell.2023.11.011Cited by 104SaveCiteExport RISWatch citationsRelated PapersMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET|Nature Medicine|2012|3.7kFuture Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout|Cancers|2025|2